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INTRODUCTION
The human T-cell leukemia cell line MOLT-4 was derived from a 19-year-old Caucasian male patient with acute lymphoblastic leukemia in 1971 by Minowada et al. , and is hypersensitive to ionizing irradiation (IR). [1] [2] [3] In response to IR, MOLT-4 cells undergo apoptosis, which is characterized by nuclear condensation and DNA fragmentation, and mediated by activated caspases. [4] [5] [6] [7] Although the reasons for the high sensitivity of MOLT-4 cells to IR have not been fully determined, previous studies have demonstrated that radiationinduced MOLT-4 apoptosis is largely p53-dependent, since either the overexpression of short hairpin (sh)-type p53 siRNA (small interfering RNA) or a dominant-negative form of p53 in MOLT-4 cells results in resistance to IR. [7] [8] [9] [10] Among the apoptosis-related p53 target gene products, PUMA (p53 upregulated modulator of apoptosis) is induced by IR in MOLT-4 cells, while Bax (BCL2-associated X protein), is not. 8, 9) However, PUMA is probably not the primary mediator of p53-dependent apoptosis in irradiated MOLT-4 cells, since a blockade of PUMA induction by transcriptional inhibitors of p53 such as pifithrin-α (PFTα) 11, 12) cannot suppress apoptosis. 9) This result suggests that the transcriptional function of p53 is not necessary for p53 to induce apoptosis. In agreement with this, the broad transcriptional inhibition by actinomycin D (ActD) was reported not to inhibit apoptosis. 13) Interestingly, that study 13) also showed that a translational inhibitor cycloheximide (CHX), contrary to ActD, suppresses apoptosis, although the relationship between the suppressive effect of CHX and p53 signaling in apoptosis has not been investigated.
Some recent findings regarding the transcription-independent apoptotic function of p53 provide a clue to the mechanisms of p53-dependent apoptosis and CHX's action in irradiated MOLT-4 cells. The alternative p53 function is a direct apoptogenic role at mitochondria, in which it jumpstarts transcription-independent apoptosis. This apoptosis is mediated by direct interactions between stress-activated p53 and mitochondrial Bcl-2 (B-cell CLL/lymphoma 2) family members, including Bcl-2, Bcl-xL (BCL2-like 1), and Bak (BCL2-antagonist/killer 1), resulting in the release of cytochrome c from the mitochondria into the cytosol. [14] [15] [16] [17] The ineffectiveness of the transcriptional inhibitors of p53 against radiation-induced MOLT-4 apoptosis 9) may thus be due to the dominance of the transcription-independent pathway and the weaker contribution of the transcriptiondependent pathway. The above-mentioned study using ActD and CHX 13) can be interpreted as supporting this hypothesis, because CHX could inhibit the protein synthesis of p53 and its subsequent accumulation, whereas the effect of ActD is primarily limited to the transactivation of p53 target genes. In support of this idea, we recently showed that an inhibitor of p53-mediated transcription-independent apoptosis, PFTμ, which was developed by Strom et al., 18) significantly suppresses radiation-induced MOLT-4 apoptosis. 9) These results strongly suggest that the transcription-independent p53 pathway is predominant in irradiated MOLT-4 cells.
In this respect, a recent study has shown that codon 72 polymorphic variants of human p53 show different sensitivities to apoptosis signals and that the Arg72 variant of p53 has a more potent apoptosis-inducing activity via the transcription-independent pathway than does the Pro72 variant. 17, 19) The potent activity of the Arg72 variant has been ascribed to its high affinity to mitochondria. The enhanced mitochondrial localization of the Arg72 variant is associated with greater binding and ubiquitination of p53 by the E3 ubiquitin ligase MDM2 (murine double minute 2; human double minute 2 (HDM2) in humans), which leads to enhanced nuclear export of the Arg72 variant. 19) Although the Pro72 allele is weaker than the Arg72 allele in inducing apoptosis and suppressing cellular transformation, it appears to be better at initiating senescence and cell-cycle arrest. 20) By comparative genomic analyses of the human TP53 gene compared with that of the chimpanzee, the Pro72 allele appears to be the older allele, currently present at a higher frequency in Africa, while the Arg72 allele arose later in Caucasians and Asians, and has spread among human populations. For example, the Arg72 homozygous allele frequency is approximately 35-40% in Caucasian Americans, but only 10-12% in African Americans. [21] [22] [23] [24] In this study, we initially found that MOLT-4 cells were homozygous for the Arg72 allele. Therefore, the opposing effects of CHX and ActD may be explained by the dominance of the transcription-independent apoptotic action of this variant. The present study sought to clarify two issues: the anti-apoptotic mechanism of CHX and the relative contribution of the Arg72 variant in the transcription-dependent and -independent MOLT-4 apoptosis.
MATERIALS AND METHODS

Cell culture and treatment
The human T-cell leukemia cell line MOLT-4, the human pre-B-cell lymphoma cell line Nalm-6, and MOLT-4 stable transfectants overexpressing the sh-type p53 siRNA (MOLT/ p53KD-1) and the negative control shRNA (MOLT/Nega) were cultured in RPMI 1640 medium (Wako, Osaka, Japan) supplemented with 10% fetal bovine serum (FBS, Gibco, GrandIsland, NY, USA) and antibiotics (100 U/ml penicillin (Meiji Seika, Tokyo, Japan) and 0.1 mg/ml streptomycin (Meiji Seika)). [8] [9] [10] The medium was also supplemented with 0.5 mg/ml G418 (Wako) for the maintenance of stable transfectants. The p53-null human osteosarcoma cell line SaOS-2 was cultured in DMEM/F12 medium (Wako) supplemented with 10% FBS and the antibiotics. Cells were maintained at 37°C in a humidified atmosphere containing 5% CO2. SaOS-2 cells were plated in 6-well plates, and transiently transfected with a Pro 72 variant of p53 vector (pCMV-p53, Clontech, Palo Alto, CA, USA) or a mock vector (pcDNA3.1, Invitrogen, Carlsbad, CA, USA) using FuGENE HD transfection reagent (Roche, Mannheim, Germany). Cell density was determined with a cell counter (Z1 Cell and particle counter, Beckman Coulter, Miami, FL, USA). Exponentially growing cell cultures (5 × 10 5 cells/ml) in tissue culture plates or flasks (Becton Dickinson, Lincoln Park, NJ, USA) were irradiated at room temperature with a 137 Cs γ-ray source (Gammacell 40, Nordion International, Kanata, Ontario, Canada) at a dose rate of 0.83 Gy/min. CHX (Wako) and ActD (Wako) were dissolved in dimethyl sulfoxide (Wako) at concentrations of 1 mg/ml and 100 μg/ml, respectively. These reagents were added to the culture medium 1 h before IR unless otherwise specified.
Immunoblotting analysis
Two million cells washed once with ice-cold PBS were lysed in 200 μl of 1 × SDS-PAGE sample buffer (62.5 mM Tris-HCl, pH 6.8, 1% sodium lauryl sulfate (SDS), 5% glycerol, 3% β-mercaptoethanol, 0.005% crystal violet), and boiled for 10 min. After centrifugation at 20,000 × g for 10 min at room temperature, the supernatant was collected as the loading sample, and then 2-20 μl of the loading samples were separated by electrophoresis through an SDSpolyacrylamide gel. Proteins in the gel were subjected to electrophoretic semi-dry transfer to a polyvinylidene difluoride membrane (Immobilon-P, Millipore, Billerica, MA, USA). The membranes were blocked with 5% nonfat milk in T-TBS (20 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.05% Tween 20) for 30 min at room temperature. These blocked membranes were incubated overnight at 4°C with an antibody against p53 (clone DO-1, Santa Cruz Biotechnology, Santa Cruz, CA, USA), PUMA (Ab-1, Calbiochem, Darmstadt, Germany), p21 (clone EA10, Calbiochem), β-actin (AC-15, Sigma, SaintLouis, MO, USA), VDAC1 (ab15895, Abcam, Cambridge, UK), or HDM2 (1:1 mixture of clone IF2 and 2A10, Calbiochem) as primary antibodies. The membranes were then washed four times with TBS-T followed by incubation for 2 h at room temperature with peroxidase-conjugated antibody against rabbit or mouse IgG (DakoCytomation, Glostrup, Denmark) as the secondary antibody. The membranes were then washed three times with TBS-T, washed twice with TBS (20 mM Tris-HCl, pH 7.6, 150 mM NaCl), and developed using an ECL-plus kit (GE Healthcare, Piscataway, NJ, USA), or Immobilon Western Chemiluminescent HRP Substrate kit (Millipore). The signals were obtained by exposure to X-ray films (Hyperfilm MP, GE Healthcare).
Genomic PCR and sequencing of exon 4 of the TP53 gene
MOLT-4 or Nalm-6 genomic DNA was isolated using the Ultra Clean Tissue DNA Isolation Kit (MO BIO, Solana Beach, CA, USA). The TP53 gene exon 4, which includes codon 72 of p53, was amplified by polymerase chain reaction (PCR) using KOD-Plus polymerase (Toyobo, Osaka, Japan). The primer sequences were as follows: forward, 5'-ACCCATCTACAGTCCCCCTTGCCGTC-3', reverse, 5'-TTGGCTGTCCCAGAATGCAAGAAGCC-3'. After heat denaturation for 2 min at 94°C, each PCR amplification for 30 cycles was performed as follows: 15 sec at 94°C and 25 sec at 68°C except that, in the last cycle, extension was carried out for 3 min, in a thermal cycler (PCR Thermal Cycler Dice, Takara, Shiga, Japan). The amplified products (275 bp) were purified and concentrated by phenolchloroform extraction and 70% ethanol precipitation, and separated by electrophoresis through a 1.5% agarose gel. The separated products were stained with 1 μg/ml ethidium bromide and visualized under UV light (365 nm), and then picked up from the gel and purified after deep-freezing (at -80°C) and thawing followed by phenol extraction and 70% ethanol precipitation. The purified DNA was subjected to PCR sequencing using the same forward primer described above and a Big Dye Terminator cycle sequencing kit (Applied Biosystems, Foster City, CA, USA) on an automated DNA sequencing system (3100 Genetic Analyzer, Applied Biosystems). Sequence data were analyzed using CodonCode Aligner V. 1.6.3 software (CodonCode Corporation, Dedham, MA, USA).
Semi-quantitative reverse transcription-PCR (RT-PCR) analysis
The isolation of total RNA from MOLT-4 cells was performed using the Ultraspec RNA isolation system (Biotecx, Houston, Texas, USA), according to the manufacturer's instructions. RNAs were converted to cDNAs using MMLV reverse transcriptase (Invitrogen), ribonuclease inhibitor (RNaseOUT, Invitrogen), and Oligo(dT) [12] [13] [14] [15] [16] [17] [18] (Invitrogen). The cDNA was then amplified by PCR using KOD-Plus polymerase. The primer sequences were as follows: p53,
After heat denaturation for 2 min at 94°C, each PCR amplification for 17 cycles (for β-actin), 22 cycles (for p53), 22 cycles (for p21), and 31 cycles (for puma) was performed as follows: 15 sec at 94°C, 30 sec at 64°C, and 30 sec at 68°C, except that, in the last cycle, extension was carried out for 3 min, in a thermal cycler (PCR Thermal Cycler Dice, Takara). The RT-PCR products were separated by electrophoresis through a 2% agarose gel, stained with ethidium bromide, and photographed by a UV transillumination system equipped with a CCD camera (PrintGraph, ATTO, Tokyo, Japan).
Measurement of viability and linear regression analyses of the relationships between the viability and the relative expression of p53 or its target gene expressions
Cell viability was determined by Annexin V-FITC and Propidium Iodide (PI) double staining using a MEBCYTO Apoptosis Kit (MBL, Nagoya, Japan), as described previously. 8, 9) The viability value was defined as the percentage of Annexin V-negative and PI-negative cells. For each sample, 10,000 cells were analyzed with a flow cytometer (FACS Calibur, Becton Dickinson). p53 and its target gene products were quantified by densitometry using Multi Gauge version 3.0 software (Fujifilm, Tokyo, Japan). Linear regression analyses were performed using Microsoft Excel 2004 for Mac software (Microsoft, Seattle, WA, USA).
Subcellular fractionation
Subcellular fractions were prepared as described by Leu et al.. 17) Since the mitochondrial fractions also contained minor contaminating endoplasmic reticulum, the mitochondrial and cytosolic fractions are referred to as Fraction 1 and Fraction 2, respectively.
9) The protein concentrations of all the samples were determined using the BCA Protein Assay Reagent (Thermo Fisher Scientific, Rockford, IL) and equalized.
RESULTS
Radiation-induced p53 in MOLT-4 cells shows a different electrophoretic mobility than the Pro72 variant of p53
In this study, we initially investigated the electrophoretic mobility of p53 in MOLT-4 cells, since the Arg72 variant of p53 shows a faster mobility than the Pro72 variant on SDSpolyacrylamide gels. [25] [26] [27] Immunoblotting analysis showed that the p53 in MOLT-4 cells exhibited a faster mobility than that in Nalm-6 cells (Fig. 1A) , which migrated between the p53 in MOLT-4 cells and the Pro72 variant of p53 expressed exogenously in SaOS-2 cells (Fig. 1B) . The faster mobility of the p53 in MOLT-4 cells suggested that it was the Arg72 variant.
MOLT-4 cells are homozygous for the allele encoding Arg72
We next analyzed the p53 exon 4 genomic DNA sequence, which includes codon 72 (Fig. 2) . As expected, MOLT-4 cells were homozygous for the Arg72 allele, and Nalm-6 cells were heterozygous (Arg72/Pro72), in agreement with their electrophoretic mobilities (Fig. 1) . Thus, the Arg72 variant of p53 in MOLT-4 cells might be expected to induce the transcription-independent pathway rather than the transcription-dependent one.
Translational inhibition by CHX suppresses p53-dependent apoptosis in irradiated MOLT-4 cells, but transcriptional inhibition by ActD has little effect on apoptosis
To determine the relative contributions of each pathway in the Arg72 variant-induced apoptosis in irradiated MOLT-4 cells, we investigated the effects of translational inhibition by CHX and transcriptional inhibition by ActD on apoptosis (Fig. 3) . The results showed that CHX strongly suppressed apoptosis, dose-dependently (Fig. 3A) , whereas ActD showed much weaker suppressions of apoptosis and p53 protein accumulation at any dose tested (Fig. 3B, D) . However, ActD effectively suppressed the transactivation of p53 target genes, puma and p21 at 100 ng/ml (Fig. 3C, D) . Notably, one of the p53 target gene products, Noxa, was not detected under any condition in our immunoblotting analysis (data not shown). These results may indicate that the apoptosis does not require any de novo synthesis of RNAs, including the expression of p53 target genes, because of the predominance of the transcription-independent pathway, while it requires the translation of certain preexisting RNAs. In the transcription-independent pathway, p53 itself is considered to be the sole determinant that is upregulated, in controlling apoptosis induction. Indeed, the expression level of p53 mRNA was unchanged after treatment with ActD or CHX (Fig. 3C) . Thus, the required translation may be of already existing p53 mRNA. To test this possibility, we next investigated the effects of CHX on the protein expressions of p53 and p53 target genes, respectively.
The suppressive effect of CHX on apoptosis is highly correlated with the suppression of p53 protein accumulation
Immunoblotting analysis revealed that CHX suppressed radiation-induced p53 protein accumulation and the transactivation of p53 target genes at different concentrations. The minimum inhibitory concentration of CHX for the transactivation (0.03 μg/ml) was insufficient to suppress apoptosis and much lower than that required to suppress p53 protein accumulation (0.3 or 1 μg/ml), which almost completely inhibited apoptosis (Fig. 3A, D) . These data indicated that p53 on its own can induce apoptosis, because it could be induced without the transactivation of p53 target genes. The relationship between the relative expression of p53 and the viability of irradiated MOLT-4 cells at each dose of CHX was highly correlated (R 2 = 0.96), but the relationships between those of PUMA and p21 and the viability were less well correlated (R 2 = 0.50 and 0.58, respectively) (Fig. 3E) . Taken together, these data strongly suggest that the transactivation of p53 target genes is not necessary to induce apoptosis in irradiated MOLT-4 cells, and that p53 itself is both necessary and sufficient to do so.
To confirm the suppressive effect of CHX on the transcription-independent pathway, we analyzed its effect on the translocation of p53 to mitochondria, a key initial event in this pathway, in fractionated MOLT-4 cells. As expected, CHX caused a dose-dependent reduction of the post-IR p53 in mitochondrial fractions (Fig. 4A, Fraction 1) . The relationship between the relative amount of p53 in Fraction 1 and the viability of irradiated MOLT-4 cells at each dose of CHX was also highly correlated (R 2 = 0.87, graph is not shown). Furthermore, we also investigated the suppressive effect of CHX on the stability of preexisting p53 in unirradiated MOLT-4 cells, since its stability is regulated by ubiquitinproteosome pathway. 28) In this immunoblotting analysis, approximately 10-fold more protein was loaded than in Fig.  3D to enable visualization of p53 in the unirradiated cells. Figure 4B shows that the suppression reached a maximum within 2-4 h after each dose of CHX, and Fig. 4C shows a dose-dependent suppression of the p53 at 2 h after treatment. In contrast, despite the fact that p53 and an E3 ubiquitin ligase for p53, HDM2, have short half-lives, [29] [30] [31] [32] HDM2 was not markedly reduced at this time probably due to its higher expression than p53 and its longer stability than that of p53 in CHX-treated MOLT-4 cells. Although the underlying mechanisms of this resistance of HDM2 to CHX in MOLT-4 cells are unclear, these results show that CHX induce the degradation of p53 prior to rupture of the cellular degradation machinery.
p53 is prerequisite for apoptosis suppression by CHX
To determine whether the suppressive effect of CHX is exerted on p53, we investigated the effect of CHX on a p53-knockdown MOLT-4 transfectant (Fig. 5) . The stable transfectant (MOLT/p53KD-1) was resistant to radiation-induced apoptosis, as reported previously. [8] [9] [10] CHX did not suppress the slow decreases in cell viability and rather slightly enhanced apoptosis in the irradiated transfectant, while a mock-transfectant (MOLT/Nega) showed similar viability curves after the treatments as the parental cells. These data indicated that p53 is essential for the apoptosis suppression by CHX.
DISCUSSION
In this study, we showed that the apoptotic signaling of the Arg72 variant of p53 in irradiated MOLT-4 cells does not require any newly synthesized RNAs, including the expression of p53 target genes, and is suppressed by CHX through an inhibition of the protein accumulation of the p53 variant. We also demonstrated that the suppressive effect of CHX on apoptosis is specifically mediated thorough the Arg72 variant, by performing an RNA interference experiment of the p53. Our data indicated that the apoptotic signaling of the Arg72 variant is transduced mainly via the transcriptionindependent pathway. The homozygosity of the Arg72 may be associated with the tendency of the p53 in MOLT-4 cells to induce the transcription-independent pathway.
To strengthen our conclusion, we performed linear regression analyses of the relationships between MOLT-4 viability and the relative expression of p53 or its target gene expressions in CHX-treated cells. These analyses showed a high correlation between the viability and the relative expression of p53, but not of its transactivation products (Fig. 3E) . In this respect, it has been reported that the p53 level is the determinant of apoptosis initiation of MOLT-4 cells. 33) Our results clearly indicated that p53 itself is the primary determinant responsible for the apoptosis sensitivity of irradiated MOLT-4 cells. Thus, MOLT-4 apoptosis can serve as a good system for studying the transcription-independent pathway.
Our data do not, however, completely exclude the possibility that the transcription-dependent pathway contributes to a small part of the MOLT-4 apoptosis. For example, CHX slightly suppressed apoptosis at 0.03 μg/ml, and almost completely inhibited apoptosis at 1 μg/ml (Fig. 3) . At 0.03 μg/ml CHX, p53 target gene expression was substantially inhibited, and apoptosis was slightly suppressed, whereas the p53 protein accumulation was less affected. This may suggest a minor contribution of the target gene products to apoptosis, although it could be explained by the slight decrease in p53. Similar results were also obtained in ActD experiments at the concentration of 100 ng/ml. Taken together, these results probably reflect a subtle contribution of the transactivation of p53 target genes to the apoptosis.
Several apoptosis-related p53 target gene products in radiation-induced apoptosis have been reported, such as Bax, 34) Noxa, 35) and PUMA. [36] [37] [38] These pro-apoptotic Bcl-2 family members have been identified as mediators of p53-dependent apoptosis because of their ability to promote apoptosis. However, a deficiency of bax or noxa does not confer any radioresistance to thymocytes. [39] [40] [41] In contrast, PUMA is regarded as the primary mediator of the transcription-dependent pathway, since its deficiency results in the resistance to radiation-induced apoptosis in thymocytes, although the radioresistance of puma-knockout mice is still not comparable to that of knockout mice in Trp53, which encodes p53. 40) A comparable level of radioresistance to Trp53 -/-thymocytes can be achieved by disrupting both the puma and noxa genes. 42) This result probably indicates that the transactivation of both genes is alone sufficient for mouse thymocytes to induce apoptosis, and that the nontranscriptional function of p53 is dispensable for the radiation-induced apoptosis of mouse thymocytes.
The difference in the requirement of the non-transcriptional function of p53 between mouse thymocytes and human Tcell-derived MOLT-4 cells may be due to the difference in cell types, because mature T-cells isolated from puma -/-and noxa -/-mouse lymph nodes are more sensitive to radiation than those from Trp53 -/-lymph nodes. 42) This may suggest that the non-transcriptional function of p53 contributes to the difference in sensitivity between the two types of cells and is required in certain cell types other than thymocytes to execute radiation-induced apoptosis. Alternatively, the difference might be due to the difference in species between mouse and human, because the mouse p53 residue corresponding to the codon 72 of human p53 is Ala (amino acid sequence identity between mouse and human p53 is 78%), 43) and such a polymorphism of p53 associated with the transcription-independent apoptotic pathway has not been found in mouse. The possible functional difference between mouse and human p53 would be worthy of further investigation.
The transcription-independent pathway is also considered to be a "jump-start" mechanism for radiation-induced apoptosis in situations in which severely injured cells cannot correctly transcribe because of DNA damage. 15, 44) We have proposed that both the transcriptional and non-transcriptional functions of p53 should be inhibited to completely block p53-mediated apoptosis and to rescue a severely irradiated mouse from gastrointestinal syndrome-induced death. 9) These studies suggest that the p53 signaling might occur more through the transcription-independent pathway as the radiation dose increases. Further research using translational and transcriptional inhibitors such as CHX and ActD should help to determine the relative contributions of each pathway with different IR doses, types of cells, or species.
